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A B S T R A C T
Spontaneous complaints of outpatients with focal epilepsy often stress the relationship between
cognitive deﬁcits and Quality of Life (QOL). Consequently, the aim of the present study was to ﬁnd the
best neuropsychological predictors of QOL in individuals with focal epilepsy, in order to guide their
ambulatory health care.
A sample of 71 Portuguese patients was studied: 40 female, 47 married, with a mean age of 37.48
years (S.D. = 11.79, 16–62), mean education of 7.93 (S.D. = 4.05, 3–17), and focal epilepsy of moderate
severity. A Socio-demographic and Clinical Questionnaire, the SF-36 v1, the Cognitive Functioning Scale
from the ESI-55, a Seizure Control scale (items from the Liverpool Seizure Severity Scale), and several
neuropsychological tests were used.
Semantic Fluency was the only predictor of Physical Functioning, Role Functioning – Physical, and
Mental Health; I.A. Test predicted Bodily Pain; and AttentiveMatrices predicted General Health, Vitality,
and Role Functioning – Emotional. The Mental Component of the SF-36 v1 was predicted by Attentive
Matrices, and the Physical Component was predicted by Semantic Fluency. Cognitive Functioning was
predicted by the Token Test. Social Functioning and Seizure Control presented no statistically signiﬁcant
correlation with the neuropsychological indicators used.
These results underscore the importance of cognitive performance to the QOL of individuals with
focal epilepsy, supporting the systematic screening of cognitive performance in this population.
Additionally, they suggest cognitive rehabilitation has the potential to improve these individuals’ QOL.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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According to the World Health Organization, Quality of Life
(QOL) is ‘‘an individual’s perception of their position in life in the
context of the culture and value system in which they live and in
relation to their goals, expectations, standards, and concerns. It is a
broad-ranging concept affected in a complex way by the person’s
physical health, psychological state, level of independence, social
relationships, and relationship to salient features of their
environment’’.1(p99)
In fact, clinical practice and research ﬁndings have been
indicating that it is necessary to use a broad framework to
encompass the variety of factors that can affect the QOL of
individuals with Epilepsy (e.g., Refs. 2–5). This idea is perfectly
straightforward if one considers the number of QOL domains that
can be relevant for individuals with Epilepsy.3,6–11 Still, it is not
clear to which point different factors contribute to the QOL of* Corresponding author. Tel.: +351 22 507 13 00; fax: +351 22 550 82 69.
E-mail address: rmeneses@ufp.edu.pt (R.F. Meneses).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.11.010individuals with Epilepsy and the reasons for the signiﬁcant
variations between them.12
There is now considerable evidence of the differences (and
similarities) between epilepsy patients and healthy subjects (e.g.,
Refs. 13–15). Several studies have also focused on the relationship
between QOL and different socio-demographic and clinical
variables (e.g., Refs. 13–16). Additionally, the QOL of epilepsy
patients has been compared with the QOL of patients with other
chronic disorders.17
Bishop and Allen18 identiﬁed ten categories or domains of QOL
in a community-based sample of adults with epilepsy. Moreover,
twelve categories of factors were identiﬁed as improving QOL; and
thirteen categories of factors were seen as reducing QOL – one of
the most frequently identiﬁed factors being cognitive limitations.
Biological, psychological and social factors were identiﬁed.
Epilepsy was seen as having both a direct and an indirect impact
on QOL, by directly affecting QOL domains and by affecting those
factors that contribute to QOL.
In this context, when research points out a role for socio-
demographic, biological/clinical, psychological, and social vari-
ables in the QOL of epilepsy patients, it seems reasonable tovier Ltd. All rights reserved.
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that can be changed. Depression, anxiety and cognitive functioning
are examples of such factors (cf., e.g., Refs. 19–30). Nevertheless,
results are not always consistent regarding the ﬁrst two factors
(e.g., Refs. 31–37).
Furthermore, it is not rare to ﬁnd that independent relation-
ships between QOL and socio-demographic or clinical epilepsy
variables is limited and that some of these variables are not
signiﬁcant predictors of QOL (e.g., Refs. 31,37).
In 1999, Perrine and Kiolbasa10 emphasized the complex
interaction between cognitive deﬁcits, humour disturbances and
QOL, defending that the relationship between them should be
assessed when one is treating Epilepsy patients. In this context it is
worth stressing that: (a) in many individuals with Epilepsy QOL is
more negatively affected by treatment side-effects than by the
seizures themselves; and that (b) both the Epilepsy and its
treatment can negatively affect cognition.38
Similarly, Austin et al.39 suggested that the neurological
condition inherent to Epilepsy (/and antiepileptic drugs) has a
negative impact over cognitive function that can: (a) directly affect
academic performance and (b) reduce the individuals’ ability to
adequately adapt to seizures. Consequently, they emphasized the
need to investigate cognitive functioning, coping strategies and
QOL.
Engelberts et al.40 studied adult outpatients with relatively
well-controlled partial epilepsy without symptomatic aetiology,
who were on carbamazepine monotherapy and matched healthy
controls. Patients had no difﬁculty with the immediate recall of
newly presented information, nor with semantic ﬂuency, and their
learning capacity was not limited. Still, patients not only stored
less information in long-term memory, but also could not easily
retrieve this information later. Additionally, their attention and
speed of information processing was lower. Self-perceived
cognitive functioning was lower than in healthy controls. QOL
was signiﬁcantly lower on domains concerned with mental
functioning in patients (vs. controls). There was no clinical factor
(age at onset, duration of epilepsy, seizure type, seizure frequency,
localization, years on carbamazepine, and dosage) that could
contribute signiﬁcantly to QOL or cognitive functioning.
In Liou et al.13 study, epilepsy patients often had difﬁculty in
thinking, learning, memory and concentration (Psychological
domain), and in Loring et al.32 study, Cognitive Difﬁculty was a
QOL predictor.
The recognition of the importance of cognitive performance to
QOL led to the construction of QOL instruments that cover this
domain (e.g., ESI-55, QOLIEs). Vickrey et al.,41 for instance, reported
that the Cognitive Function Scale from the ESI-55 (self-perception
of functioning) correlated with Emotional Well-Being and General
QOL in individuals with Epilepsy. Nevertheless, Wilson and
Goetz,42 recognizing the importance of the subjective assessment
of cognitive functioning in QOL assessment, maintained that such
assessment may be inﬂuenced by external factors (e.g., depres-
sion). Consequently, they also suggested the consideration of a
direct measure of cognitive performance.
Hermann43 even supported that any QOL model that does not
include the area of cognitive functioning is incomplete. Defending
that neuropsychological and QOL assessments, being complemen-
tary, are not synonyms, he sustains their integration.
Leidy et al.44 were the ﬁrst to assess the performance of a QOL
measure in light of the memory deﬁcit. Those individuals with
memory deﬁcits had signiﬁcantly worse QOL than the ones
without memory deﬁcits; there were no differences between the
groups in the Mental Health domain only.
The results from Perrine et al.45 suggested that some cognitive
variables seem to be more strongly related to QOL than others.
Neuropsychological tests and self-reports of cognitive functioningwere signiﬁcant predictors of Global QOL; humour was a strong
moderating variable explaining much of the impact of cognitive
functioning over QOL.45
Breier et al.46 showed a signiﬁcant relationship between
cognitive performance and cognitive functioning perception
(QOL domain), independent of depression. Similarly, Giovagnoli
and Avanzini47 found that QOL was signiﬁcantly associated with
humour and memory: both the objective memory deﬁcit and the
perception of deﬁcit affected the QOL of the sample. They also
found that memory perception was associated with humour,
memory tests, age, seizure frequency, lesion status, and Epilepsy
localization.
On the other hand, Mihara et al.48 compared memory self-
assessment with neuropsychological assessment in individuals
submitted to Temporal Lobe Epilepsy surgery, ﬁnding no
correlation.
It is worth stressing that the data already gathered concerning
the factors associated with/that contribute to the QOL of epilepsy
patients have been used to assess treatment strategies and to
develop new intervention efforts (e.g., Refs. 49–53).
In sum, research on the contributors of epilepsy patients’ QOL
can have a considerable impact on the health care offered to them
(cf. Refs. 54–56). Nevertheless, there is a paucity of publishedwork
analysing cognitive rehabilitation as a way to improve adult
epilepsy patients QOL (e.g., Ref. 57). In this context, the aim of the
present study is to analyse the predicting role of some cognitive
performance indicators on the QOL of a group of Portuguese adults
with focal epilepsy.
2. Materials and methods
2.1. Participants
A consecutive sample of 71 Portuguese epilepsy patients was
studied. To be considered for the study, patients had to have 16 or
more years but less than 66 years of age (cf. cerebral maturation),
clinical evidence of focal epilepsy (temporal or frontal) according
to their neurologist, but no evidence of communication or
psychiatric disorder that could limit the administration of the
battery.
Taken these criteria into account, the neurologists of the Unit
selected a total of 100 outpatients during a 3-year period (cf.
funding for a PhD research project). The selection was based on
outpatient records reviewed weakly or on EEG request forms
reviewed daily. Further investigation (e.g., EEG report) showed
that, among those patients selected based on EEG request forms
(methodology considered in order to speed up the selection
process), 25 did not fulﬁlled the inclusion criteria presented earlier
(namely, did not have focal epilepsy). Of the remaining 75, 4 did
not undergo neuropsychological assessment due to their personal
time constraints.
The ﬁnal sample’s socio-demographic and clinical character-
ization is shown in Tables 1 and 2, respectively. The analysis of
both tables indicates that the majority of participants were female
and married/cohabiting, with a mean age 37.48 years, mean
education of 7.93 years, and focal epilepsy of moderate severity.
It is also worth mentioning that Epilepsy Onset took place
between .25 and 46.0 years before assessment (M = 16.84,
S.D. = 11.13), when participants had a mean age of 20.65 years
(S.D. = 12.91, 1–57).
2.2. Materials and procedure
A Socio-demographic and Clinical Questionnairewas developed
to characterize the sample. For precaution (cf. Ref. 58), the
questionnaire had a mixed structure: items to be completed
Table 1
Socio-demographic characteristics of the sample.
Socio-demographic variables Number of cases (%) (N = 71)
Gender
Females 40 (56.3%)
Males 31 (43.7%)
Mean age (S.D.) (Amplitude) (years) 37.48 (11.79) (16–62)
Mean education (S.D.) (Amplitude) (years) 7.93 (4.05) (3–17)
Marital status
Married/cohabiting 47 (66.2%)
Single 21 (29.6%)
Widow 2 (2.8%)
Separate/divorced 1 (1.4%)
Occupation
Employed 49 (69.0%)
Unemployed 2 (2.8%)
Students 10 (14.1%)
Retired 10 (14.1%)
Laterality
Right-handed 63 (88.7%)
Left-handed 5 (7.0%)
Ambidextrous 3 (4.2%)
Table 2
Clinical characteristics of the sample.
Clinical Variables Number of cases (%)a Valid cases
Pharmacological therapy 71
Without medication 4 (5.6%)
Monotherapy 36 (50.7%)
Two medications 22 (31.0%)
More than two medications 9 (12.7%)
Medication side-effects 67
Without 55 (77.5%)
With 12 (16.9%)
Single type of seizures 49 (69.0%) 71
Only simple partial 2 (2.8%)
Only complex partial 21 (29.6%)
Only secondarily generalized partial 7 (9.9%)
Only generalized tonic clonic 19 (26.8%)
Seizure frequency 71
Daily 3 (4.2%)
More than one/week 5 (7.0%)
One or less/week 2 (2.8%)
More than one/month 15 (21.1%)
One or less/month 9 (12.7%)
More than one/year 6 (8.5%)
One or less/year 15 (21.1%)
Without seizures for three or more years 9 (12.7%)
Unknown 7 (9.9%)
Epileptogenic focus localization 71
Temporal 47 (66.2%)
Frontal 13 (18.3%)
Frontotemporal 9 (12.7%)
Frontoparietal 2 (2.8%)
Focus lateralization 71
Left hemisphere 36 (50.7%)
Right 19 (26.8%)
Bilateral 4 (5.6%)
Not precise 12 (16.9%)
With other diseases 20 (28.2%) 71
Other medications associated 12 (16.9%) 71
a The percentages always refer to the total sample (N = 71), even though there are
missing cases in some items, due, for instance, to their inadequacy for some
participants. In these cases, the number of individuals that ‘‘answered’’ is shown in
the third column.
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completed through the analysis of his/her clinical records. Due
to protocol length, and the limitations of preference inventories
and mastery measures, a standardized laterality measure was not
used. Instead, the items 1 (write), 6 and 7 (eat) from the Edinburgh
Handedness Inventorywere used,which correspond to items 1 and
9 from the Test for Handedness and to item 1 from Handedness
Research.59 They, roughly, allowed the determination of the
participants’ laterality. Based on the Handedness Research,
participants were also asked if there was any activity they
performed with the other hand.59 Additionally, the item covering
medication side-effects is a short version of the neurological
examination undertaken in the assessment of the QOLIE-based in
neurotoxicity and systemic toxicity scales.60 Finally, it is worth
mentioning that data concerning seizure type and frequency was
gathered through the analysis of patients’ clinical records.
QOL was measured using the Portuguese version of the SF-36
v1.0,61 complemented by nine epilepsy speciﬁc items, covering
Cognitive Functioning (Cognitive Functioning Scale from the ESI-
55, i.e., items 35, 36, 38, 49, and 5062), and Seizure Control (items 2,
3, 4, and 5 from the Control Perception subscale of the Liverpool
Seizure Severity Scale – LSSS7,63–65), in a total of 11 scores (SF-36:
Physical Functioning, Role Functioning – Physical, Bodily Pain,
General Health, Vitality, Social Functioning, Role Functioning –
Emotional, and Mental Health scale scores (0–100; a higher score
indicates better QOL), Mental and Physical Component scores (0–
100; a higher score indicates better QOL), and Reported Health
Transition score (single item; ‘‘much better now than one year ago’’
to ‘‘much worse now than one year ago’’); Cognitive Functioning
score (0–100; a higher score indicates better QOL); and Seizure
Control score (4–16; a higher score indicates worse QOL)).
Several neuropsychological tests were also used: Logical
Memory (only the A version; immediate and 30 delayed recall66),
Attentive Matrices,67 Rey Complex Figure (immediate and 30
delayed recall68), Semantic Fluency,69 Wisconsin Card Sorting Test
(Nelson’s version–WCSTNv70), Token Test,71 Digit Span,66 Corsi
Span,67 and I.A. Test (similar to the Raven Matrices72).
The following neuropsychological test scores were used:
Logical Memory I and II – total score (0–24; a higher score
indicates better performance); Attentive Matrices – correct
answers (0–60; a higher score indicates better performance);
Rey Complex Figure I and II – points (0–36; a higher score indicates
better performance); Semantic Fluency – total score (no limit; a
higher scores indicates better performance); WCSTNv – categories
(0–6; a higher scores indicates better performance), errors (no
limit), divided into perseverative errors and non-perseverative
errors, and percentage of perseverative errors; Token Test – total
score (0–22; a higher scores indicates better performance); Digit
Span – total score (3–9; a higher scores indicates better
performance); Corsi Span – total score (2–10; a higher score
indicates better performance), and I.A. Test (0–30; a higher score
indicates better performance).
The decision making process regarding the methods to assess
QOL and cognition involved: literature review on the cognitive
functions usually impaired in temporal and frontal lobe epilepsy;
literature reviewon neuropsychological tests usually administered
to assess such functions not only but also to (focal) epilepsy
patients; literature review on the QOL instruments usually
administered to (focal) epilepsy patients; literature review and
consultation with experts (from the North, Centre, and South
regions of the country) to identify which of the previously listed
instruments had European Portuguese versions; literature review
on the psychometric characteristics of the instruments (and, when
appropriate, the different versions of each); literature review and
expert consultation on protocol length, burden, and clarity/
simplicity; ﬁnally, the simplicity and time needed to administer,
Table 3
Quality of life scores.
QOL indicators M S.D. Amplitude Valid cases
SF-36 v1 71
Physical Functioning 87.81 15.96 35–100
Role Functioning – Physical 75.00 35.10 0–100
Bodily Pain 68.53 29.88 0–100
General Health 53.42 19.27 20–92
Vitality 54.57 25.42 0–100
Social Functioning 82.21 23.01 0–100
Role Functioning – Emotional 69.01 38.76 0–100
Mental Health 58.08 23.53 4–100
Mental Component 65.97 22.71 11.33–98.75
Physical Component 71.19 19.09 28.00–98.00
Cognitive Functioning (ESI-55) 60.31 23.76 4–100 71
Seizure Control (LSSS) 10.60 3.68 5–16 45
Table 4
Neuropsychological scores.
Neuropsychological indicators M S.D. Amplitude Valid cases
Logical Memory I 8.21 3.93 1–18 71
Logical Memory II 12.19 4.83 3–23 69
Attentive Matrices (correct) 49.17 9.24 18–59 71
Rey Complex Figure I (points) 31.10 4.15 16–36 65
Rey Complex Figure II (points) 16.46 6.46 1–32 64
Semantic Fluency 35.39 10.72 14–62 71
WCSTNva Categories 3.77 1.91 0–6 71
WCSTNv Errors 17.72 10.75 1–42 71
WCSTNv Perseverative Errors 6.42 8.01 0–42 71
WCSTNv Non-perseverative Errors 11.30 6.91 0–27 71
WCSTNv % of Perseverative Errors 30.75 21.29 0–100 71
Token Test 19.15 2.97 9.5–22 67b
Digit Span 5.46 1.32 3–9 71
Corsi Span 4.73 0.91 3–7 71
I.A. Test 13.31 5.60 3–26 68
a WCSTNv-Wisconsin Card Sorting Test Nelson’s version.
b Themajority of missing cases was due to an inability to distinguish circles from
squares.
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account as there was only a psychologist responsible for all the
assessments (RFM). The criteria supporting the choice of each
instrument used are thoroughly presented in Meneses.5
The psychometric characteristics of the instruments used
(considering internal consistency – Cronbach a; content validity
– instruments’ selection process; construct validity – sensitivity to
co-morbidity and non-AED medication/principal components
analysis, Varimax rotation, Kaiser normalization of the neuropsy-
chological battery) were acceptable to good.
The standardized instructions (/a Portuguese translation) and
scoring guidelines were followed. All instruments were adminis-
tered in the context of an individual interview by the ﬁrst author,
with training in the assessment procedures.
Internationally accepted ethical principles were followed.
Consequently, the proper institutional approval was obtained
and the study has been carried out in accordance with The Code of
Ethics of the World Medical Association (Declaration of Helsinki)
for experiments involving humans73 and the Ethical Principles of
Psychologists and Code of Conduct of the American Psychological
Association.74
With the Statistical Package for the Social Sciences (SPSS) 15.0,
descriptive analysis of the sample were done using the mean,
standard deviation, amplitude, frequencies (and percentages);
Pearson correlations (2-tailed) were calculated to explore the
association between QOL and neuropsychological scores; regres-
sion analysis – Linear Regression, Method Stepwise – was used to
ﬁnd the neuropsychological predictors of QOL, according to
Pestana and Gageiro.75
In more detail, to achieve the aim of the study, ﬁrst the
correlation between the cognitive performance indicators (pre-
dictors or independent variables) and the QOLmeasures (predicted
or dependent variable) was inspected, followed by the inspection
of the joint contribution of the predictor variables on QOL.
Regression analysis is applied to a data set in which the predictor
variables are correlated with one another and with the predicted
variable to varying degrees, and to determine the importance of
each of the predictors for the relationship.
It was considered that a rule of thumb and generally accepted
arbitrary statistical power value is .80 (1  b = .80). A sample size
necessary for a correlation of r = .30 with a conﬁdence level of 95%
needs to include at least 67 subjects.
3. Results
Tables 3 and 4 show the mean, standard deviation, and
amplitude of the scores obtained by the participants on the QOL
and neuropsychological indicators, respectively. The variability of
the scores is the most prominent ﬁnding.
As far as the Reported Health Transition (SF-36) is concerned
(‘‘Compared to one year ago, how would you rate your health in
general now?’’), 22.5% of participants reported they were ‘‘much
better now than one year ago’’, 21.1% reported they were
‘‘somewhat better now than one year ago’’, 47.9% reported they
were ‘‘about the same as one year ago’’, and 8.5% reported they
were ‘‘somewhat worse now than one year ago’’. No one reported
being much worse.
Table 5 shows the Pearson correlations between the QOL and
neuropsychological scores of the sample. Social Functioning and
Seizure Control were the only QOL indicators that presented no
statistically signiﬁcant correlation with the neuropsychological
indicators used.
Considering the statistical power described before, the correla-
tion values for the Physical Component of SF-36 with Attentive
Matrices, Semantic Fluency, and I.A. test reject the null hypotheses
and the effect found probability exists. The same is true for therelationship between Mental Component of SF-36 and the results
of Attentive Matrices. Other results of correlation are above the
1  b = .80, namely for General Health, Vitality and Mental Health.
Considering the correlations between the different WCSTNv
indicators, only the number of categories achievedwas used for the
regression analysis (Linear Regression, Method Stepwise). For the
regression analysis the QOL scores were used as dependent
variables and the neuropsychological scores as independent
variables.
Semantic Fluency was the only predictor of Physical Function-
ing (R2a = .07, p = .01), Role Functioning – Physical (R
2
a = .08,
p = .007), andMental Health (R2a = .09, p = .005); I.A. Test predicted
Bodily Pain (R2a = .07, p = .01); and Attentive Matrices predicted
General Health (R2a = .20, p = .000), Vitality (R
2
a = .09, p = .006), and
Role Functioning – Emotional (R2a = .06, p = .01). The Mental
Component of the SF-36 v1 was predicted by Attentive Matrices
(R2a = .09, p = .006), and the Physical Component was predicted by
Semantic Fluency (R2a = .16, p = .000). Cognitive Functioning was
predicted by the Token Test (R2a = .05, p = .03).
Consequently, in the present sample the neuropsychological
indicators explain little of the QOL variance, except for General
Health and Physical Component.
4. Discussion
Language (Semantic Fluency and Token Test performance),
General Intelligence (I.A.Testperformance), andAttention(Attentive
Matrices performance) were the best neuropsychological predictors
of the sample’sQOL. Consequently, thesepreliminary results support
Table 5
Pearson correlations (2-tailed) between the quality of life and neuropsychological scores.
LMa 1 AM LM 2 RCF 1 SF RCF 2 WCST cat WCST e WCST npe WCST pe WCST % pe TT DS CS IA
PF r .01 .17 .03 .16 .25 .21 .14 .13 .10 .09 .00 .04 .00 .15 .27
p .88 .13 .80 .18 .03 .08 .23 .27 .40 .45 .96 .73 .96 .20 .02
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
RFP r .15 .20 .20 .10 .31 .13 .09 .11 .10 .06 .03 .07 .10 .07 .19
p .21 .09 .08 .42 .00 .27 .42 .32 .37 .57 .77 .54 .40 .51 .11
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
BP r .10 .27 .17 .11 .27 .18 .29 .29 .24 .18 .04 .00 .10 .15 .29
p .36 .02 .15 .36 .02 .14 .01 .01 .04 .12 .68 .95 .39 .20 .01
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
GH r .04 .46 .14 .16 .34 .14 .31 .26 .14 .23 .04 .06 .11 .17 .26
p .72 .00 .24 .19 .00 .24 .00 .02 .22 .05 .73 .57 .33 .14 .03
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
V r .07 .32 .04 .01 .24 .01 .06 .08 .13 .01 .00 .02 .08 .16 .14
p .53 .00 .74 .92 .04 .88 .57 .50 .25 .93 .99 .84 .48 .16 .22
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
MH r .19 .29 .17 .04 .32 .20 .09 .07 .00 .09 .07 .09 .14 .21 .23
p .10 .01 .15 .72 .00 .10 .42 .51 .93 .41 .53 .45 .21 .07 .05
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
RFE r .09 .27 .08 .00 .20 .01 .05 .02 .07 .03 .05 .10 .07 .05 .07
p .42 .01 .50 .96 .08 .91 .67 .86 .54 .76 .66 .40 .55 .62 .55
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
SF r .07 .15 .06 .16 .06 .01 .09 .11 .06 .10 .13 .09 .17 .05 .06
p .52 .19 .58 .18 .59 .88 .44 .32 .57 .40 .26 .47 .15 .62 .62
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
MC r .09 .32 .07 .02 .25 .05 .03 .04 .08 .01 .00 .05 .04 .14 .11
p .43 .00 .54 .81 .03 .64 .74 .73 .48 .88 .95 .69 .68 .23 .34
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
PC r .11 .35 .20 .16 .39 .21 .26 .26 .20 .18 .04 .05 .11 .17 .32
p .32 .00 .09 .18 .00 .08 .02 .02 .09 .13 .70 .64 .33 .15 .00
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
SC r .13 .15 .10 .15 .10 .18 .12 .16 .12 .11 .05 .11 .01 .08 .03
p .36 .31 .52 .32 .47 .25 .39 .28 .42 .45 .71 .48 .90 .56 .80
N 45 45 43 41 45 40 45 45 45 45 45 43 45 45 43
CF r .15 .10 .01 .21 .15 .06 .10 .11 .13 .04 .07 .25 .08 .03 .18
p .20 .40 .93 .09 .18 .63 .37 .32 .26 .73 .54 .03 .50 .75 .13
N 71 71 69 65 71 64 71 71 71 71 71 67 71 71 68
Bold numbers represent statistically signiﬁcant correlations.
a PF: Physical Functioning; RFP: Role Functioning Physical; BP: Bodily Pain; GH: General Health; V: Vitality; MH: Mental Health; RFE: Role Functioning Emotional; SF:
Social Functioning;MC–Mental Component; PC: Physical Component; SC: Seizure Control; CF: Cognitive Functioning; LM: LogicalMemory; AM: AttentiveMatrices; RCF: Rey
Complex Figure; SF: Semantic Fluency;WCST cat:Wisconsin Card Sorting Test categories;WCST e:WCST errors;WCST npe:WCST non-perseverative errors;WCST pe:WCST
perseverative errors; WCST % pe: WCST percentage of perseverative errors; TT: Token Test; DS: Digit Span; CS: Corsi Span; IA: I.A. Test.
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epilepsy of moderate severity. More speciﬁcally, Language, General
Intelligence, and Attention may be particularly important. Unfortu-
nately, the absence of Portuguese normative values makes it
impossible toknowif theneuropsychologicalperformanceexhibited
by patients was out of the normal range. That is, it is unknown if the
predicting value of the neuropsychological tests used reﬂects the
awareness of certain cognitive deﬁcits. Regrettably, this state of
affairs is not rare in the literature, evenwhen there is a careful choice
of instruments (cf., e.g., Ref. 76).
Consequently, the results suggest the importance of system-
atically screening forcognitiveperformance in individualswith focal
epilepsy. They also suggest the need of correct focus identiﬁcation,
even when Epilepsy is of moderate severity, and, in the absence of
normative values, the need to compare the scores obtained with
those of matched controls. Additionally, they suggest cognitive
rehabilitation (namely, of attention) has the potential to improve
these individuals’ QOL. This hypothesis must be tested after
guaranteeing that patients do have cognitive deﬁcits.
Other aspects are also worth mentioning. The ﬁrst has to do
with the considerable variability in the QOL and neuropsycholo-gical scores of the sample. Of course that this can be a mere
reﬂection of the age and educational diversity of the sample, but it
can also mean that individuals with focal epilepsy of moderate
severity do not constitute a homogeneous group. This has
signiﬁcant clinical implications, namely if one considers promoting
patients QOL and/or cognitive rehabilitation.
There were several statistically signiﬁcant correlations, of low
to moderate intensity, between QOL and neuropsychological
indicators, similar to those of Giovagnoli and Avanzini.47 These
correlations underscore that some QOL dimensions are more
intimately related with cognitive performance than others (cf. Ref.
45). Devinsky et al.60 had similar results.
As could be expected, Physical Functioning and Role Function-
ing – Physical correlatedwith few neuropsychological scores: with
those that were consistently related to the physical domain (I.A.
Test) and/or with most QOL scores (Semantic Fluency). If one
considers that Bodily Pain, Vitality, and General Health are
intimately related domains, a similar pattern of relationships
between these indicators and neuropsychological scores is to be
expected. It makes sense that the recent experience of pain,
generally independent of epilepsy, has a negative impact over the
R.F. Meneses et al. / Seizure 18 (2009) 313–319318perception of general health and vitality. Additionally, if one
considers the potentially negative effect of pain on attention and
motivation – central to a good neuropsychological performance –
the relationship between pain and several neuropsychological
scores, which has been reported in the literature, is understandable
(e.g., Ref. 77). The statistically signiﬁcant correlation found by
Perrine et al.45 between the language factor and Energy/Fatigue
can be considered similar to the relationship between Semantic
Fluency and Vitality found in the present study.
The relationship betweenMentalHealth andneuropsychological
performance is widely recognized (cf., e.g., Ref. 78). Even so, Leidy
et al.44 found that individuals withmemory deﬁcits had statistically
worse QOL scores than individuals without deﬁcits, except in the
Mental Health domain (no statistically signiﬁcant differences were
found). Additionally, the association between Role Functioning –
Emotional and performance on the Attentive Matrices is to be
expected if one considers item 5c (careful performance).
Even though the complexity of the relationship between
cognitive complaints and performance is unarguable (e.g., Ref.
79), the exclusive relationship between Cognitive Functioning and
performance on the Token Test is unexpected and deserves future
exploration.Maybe it is due to the fact that performance perception
reﬂects conditions other than cognitive difﬁculties (e.g., depression,
other subjective factors).47,79 It is alsopossible that different typesof
complaints related to a speciﬁc function are differentially associated
to different ‘‘objective’’ tests of that function.79 Therefore, the
Cognitive Functioning Scalemay not be themost adequate to screen
for deﬁcits assessed by the tests chosen, or vice-versa. In fact, with
different instruments, Devinsky et al.60 and Perrine et al.,45 for
instance, obtained statistically signiﬁcant correlations between
cognitive functioning perception (attention/concentration,memory
and language) and performance on neuropsychological tests of the
same functions. Inversely, Mihara et al.48 and Perrine et al.45 found
that some results of neuropsychological testing (e.g., with the RCF)
had no statistically signiﬁcant correlations with QOL/performance
perception scales (cf. Social Functioning in the present study). It is
also worth remembering that Breier et al.46 only found statistically
signiﬁcant correlations between the QOLIE Language scale and the
neuropsychological test for language in individuals with left partial
seizures. Since themajority ofparticipants of thepresent studyhada
left focus this may have had a certain inﬂuence on the relationship
found between Cognitive Functioning and the Token Test score (a
language test). Be as it may, the present results indicate, oncemore,
that there is no simple relationship between ‘‘objective’’ perfor-
mance and ‘‘subjective’’ perception in Epilepsy patients.
In sum, the present results support Hermann’s43 point of view –
any QOL model that does not include Cognitive Functioning is
incomplete – and that of Wilson and Goetz42 – ‘‘objective’’ and
‘‘subjective’’ assessments of cognition should be performed in QOL
research.
In terms of future research, namely in Portugal, the present
results highlight the need to clarify the relationship between
gender, age, schooling/literacy and cognitive performance, and not
only in epilepsy patients, since the international literature has
contradictory data. Portuguese norms, considering such relation-
ships, will allow the detection of deﬁcit and strength patterns that
can be the basis for cognitive rehabilitation programs. It will also
allow us to verify if memory is, in fact, one of the most affected
functions. Obviously, the establishment of Portuguese norms calls
for a deeper knowledge about the instruments (e.g., psychometric
properties, relationships between instruments). Additionally, it is
essential to investigate what is behind every cognitive complaint,
i.e., cognitive factors or other type of factors.
Considering the relationships found, it makes sense to assume
that changing cognitive performance (by means of cognitive
rehabilitation) can lead to (direct or indirect) changes in QOLperception. In this context, the results of the present study suggest
that different cognitive functions may be rehabilitation targets in
order to promote certain QOL domains: rehabilitating attention (cf.
Attentive Matrices) might have an impact on Bodily Pain, General
Health, Vitality, Mental Health and Role Functioning–Emotional
(and SF-36 Mental and Physical Components); rehabilitating
language (cf. Semantic Fluency and Token Test) might have an
impact on every QOL domain studied, except Role Functioning –
Emotional, Social Functioning (Cognitive Functioning) and Seizure
Control; rehabilitating executive functions (cf. WCST) might have
an impact on Bodily Pain and General Health (and Physical
Component); rehabilitating general intelligence (cf. I.A. Test)might
have an impact on Physical Functioning, Bodily Pain, and General
Health (and Physical Component).
The opposite possibility can also be raised: can QOL promotion
enhance cognitive functioning? Regression analysis, even though
unable to deny this possibility, suggests that it is the other way
around. Since the predicting value of the neuropsychological
indicators was not very high, the search for other predictors of QOL
seems urgent in order to promote these patients QOL.
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